Elemé Medical will present at Leerink Swann/MEDACorp’s ''Aesthetics Roundtable''

CEO Nancy Briefs to discuss Company’s Photomology™ technology and SmoothShapes™ 100 System for cellulite treatment, a key segment of the body shaping sector Webcast available Wednesday, Oct. 3, 11:40 a.m. EDT

MERRIMACK, N.H.--(EON:Enhanced Online News)--Elemé Medical Inc., a premier aesthetics company that is entering the body shaping market with an initial focus on cellulite, announced today that its president and CEO, Nancy M. Briefs, will present a corporate overview and update at Leerink Swann & Company/MEDACorp’s “Taking a Dip in the Fountain of Youth: Aesthetics Roundtable Conference” tomorrow, Wednesday, Oct. 3, at 11:40 a.m. EDT at The Grand Hyatt New York.

“definitely continue ongoing maintenance treatments; and, 77% would “definitely recommend the procedure to a friend.”

A live webcast of the Elemé Medical presentation at the Leerink Swann/MEDACorp “Aesthetics” conference can be accessed on the Internet by visiting www.elememedical.com. The roundtable conference is a one-day format consisting of a series of moderated discussions with panels of MEDACorp research and clinical experts and key members of management from the companies attending the conference. The conference also will feature a separate discussion for company management to interact directly with MEDACorp’s top-tier health care investors.

The SmoothShapes 100 System is FDA-cleared and indicated for the temporary reduction in the appearance of cellulite. It is based on pioneering Photomology, an exclusive process that treats cellulite and subcutaneous fat by combining dynamic light and laser energy along with vacuum massage to gently stimulate natural cell processes and modify cell activity, resulting in tighter, smoother-looking skin and slimmer-looking body. In a multicenter, prospective, randomized and controlled clinical study of the SmoothShapes 100 System (“Physiological effects of transcutaneous multiwavelength laser light administration”) 81% of 74 patients treated showed reduction in subcutaneous fat in the ‘treated’ versus ‘untreated’ leg. Equally impressive, 92% of treated patients felt the SmoothShapes 100 treatment was “comfortable”; 80% would “definitely continue ongoing maintenance treatments; and, 77% would “definitely recommend the procedure to a friend.” Targeted markets for SmoothShapes 100 include not only core practitioners of aesthetic procedures—plastic surgeons and dermatologists—but also non-core practitioners, such as OB/GYN and primary care specialists, as well as medi-spas, aesthetic clinics and health clubs.

Elemé Medical Inc., headquartered in Merrimack, N.H., is focused on commercializing its first product based on the Company’s pioneering Photomology™ technology: the SmoothShapes™ 100 System for the treatment of cellulite. The Company’s name, when spoken phonetically, suggests “lasers, medicine and aesthetics”. By applying lasers and other medical technologies for aesthetic purposes in scientifically proven protocols, Elemé reflects its clients’ eagerness to improve and preserve their individual appearance.